FDA approves new treatment for adults with mantle cell lymphoma - FDA.gov

KFGO

FDA approves new treatment for adults with mantle cell lymphoma FDA.gov The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive ... FDA approves AstraZeneca's Calquence for rare blood cancerReuters AstraZeneca wins US approval for lymphoma drugABC News FDA Approves Calquence for Mantle Cell LymphomaCuretoday.com Healio -Rare Disease Report (blog) -Specialty Pharmacy Times (blog) -Targeted Oncology all 14 news articles »

from Health - Google News http://ift.tt/2z7D376